{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:27:10Z","timestamp":1782602830224,"version":"3.54.5"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s11239-020-02297-z","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T20:02:25Z","timestamp":1602792145000},"page":"657-662","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of complement system inhibition in COVID-19"],"prefix":"10.1007","volume":"51","author":[{"given":"Xin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0382-6882","authenticated-orcid":false,"given":"Kamal Kant","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Cerny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,15]]},"reference":[{"issue":"4","key":"2297_CR1","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.4103\/jfmpc.jfmpc_424_20","volume":"9","author":"KK Sahu","year":"2020","unstructured":"Sahu KK, Kumar R (2020) Current perspective on pandemic of COVID-19 in the United States. J Family Med Prim Care 9(4):1784\u20131791","journal-title":"J Family Med Prim Care"},{"key":"2297_CR2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, Chine: a descriptive study. Lancet 395:507\u2013513","journal-title":"Lancet"},{"issue":"11","key":"2297_CR3","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323(11):1061\u20131069","journal-title":"JAMA"},{"key":"2297_CR4","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan China: a retrospective cohort study. Lancet 395:1054\u20131062","journal-title":"Lancet"},{"key":"2297_CR5","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","volume":"46","author":"J Helms","year":"2020","unstructured":"Helms J, Tacquar C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X et al (2020) High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 46:1089\u20131098","journal-title":"Intensive Care Med"},{"key":"2297_CR6","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14888","author":"S Middeldorp","year":"2020","unstructured":"Middeldorp S, Coppens M, van Haaps TF, Foppen M, Vlaar AP, Muller MCA et al (2020) Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. https:\/\/doi.org\/10.1111\/jth.14888","journal-title":"J Thromb Haemost"},{"key":"2297_CR7","first-page":"1","volume":"4","author":"J Helms","year":"2020","unstructured":"Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X et al (2020) High risk of thrombosis in patients in severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 4:1\u201310","journal-title":"Intensive Care Med"},{"issue":"8","key":"2297_CR8","first-page":"E213","volume":"95","author":"KK Sahu","year":"2020","unstructured":"Sahu KK, Siddiqui AD (2020) From hematologist\u2019s desk: the effect of COVID-19 on the blood system. Am J Hematol 95(8):E213\u2013E215","journal-title":"Am J Hematol"},{"issue":"Suppl 1","key":"2297_CR9","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s12288-015-0539-9","volume":"32","author":"KK Sahu","year":"2016","unstructured":"Sahu KK, Law AD, Kumar G, Dhir V, Naseem S, Nada R, Varma SC, Malhotra P (2016) Unusual cause of tophi with renal thrombotic microangiopathy. Indian J Hematol Blood Transfus 32(Suppl 1):100\u2013103","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"23","key":"2297_CR10","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1182\/blood.2020006000","volume":"135","author":"JM Connors","year":"2020","unstructured":"Connors JM, Levy JH (2020) COVID-19 and its implications for thrombosis and anticoagulation. Blood 135(23):2033\u20132040","journal-title":"Blood"},{"issue":"12","key":"2297_CR11","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1161\/ATVBAHA.108.177402","volume":"29","author":"S Butenas","year":"2009","unstructured":"Butenas S, Orfeo T, Mann KG (2009) Tissue factor in coagulation: Which? Where? When? Arterioscler Thromb Vac Biol 29(12):1989\u20131996","journal-title":"Arterioscler Thromb Vac Biol"},{"key":"2297_CR12","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/CIRCRESAHA.116.306853","volume":"118","author":"JH Foley","year":"2016","unstructured":"Foley JH, Conway EM (2016) Cross talk pathways between coagulation and inflammation. Circ Res 118:1392\u20131408","journal-title":"Circ Res"},{"key":"2297_CR13","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","volume":"86","author":"FB Taylor","year":"2001","unstructured":"Taylor FB, Toh CH, Hoots WK, Wada H, Levi M et al (2001) Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86:1327\u20131330","journal-title":"Thromb Haemost"},{"key":"2297_CR14","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/jth.14578","volume":"17","author":"T Iba","year":"2019","unstructured":"Iba T, Levy JH, Warkentin TE, Thachil J, van der Poll T, Levi M et al (2019) Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J Thromb Heemost 17:1989\u20131994","journal-title":"J Thromb Heemost"},{"issue":"6","key":"2297_CR15","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","volume":"7","author":"M Levi","year":"2020","unstructured":"Levi M, Thachil J, Iba T, Levy JH (2020) Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol 7(6):e438\u2013e440","journal-title":"Lancet Haematol"},{"issue":"5","key":"2297_CR16","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","volume":"86","author":"FB Taylor","year":"2001","unstructured":"Taylor FB, Toh CH, Hoots WK, Wada H, Levi M (2001) Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86(5):1327\u20131330","journal-title":"Thromb Haemost"},{"key":"2297_CR17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet 395:497\u2013506","journal-title":"China Lancet"},{"issue":"1","key":"2297_CR18","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/22221751.2020.1746199","volume":"9","author":"L Lin","year":"2020","unstructured":"Lin L, Lu L, Cao W, Li T (2020) Hypothesis for potential pathogenesis of SARS-CoV-2 infection\u2014a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect 9(1):727\u2013732","journal-title":"Emerg Microbes Infect"},{"issue":"10234","key":"2297_CR19","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS et al (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet Lond Engl 395(10234):1417\u20131418","journal-title":"Lancet Lond Engl"},{"issue":"4","key":"2297_CR20","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","volume":"181","author":"V Monteil","year":"2020","unstructured":"Monteil V, Kwon H, Prado P, Hagelkr\u00fcys A, Wimmer RA, Stahl M et al (2020) Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell 181(4):905\u2013913","journal-title":"Cell"},{"key":"2297_CR21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","volume":"383","author":"M Ackermann","year":"2020","unstructured":"Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F et al (2020) Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 383:120\u2013128","journal-title":"N Engl J Med."},{"issue":"2","key":"2297_CR22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/01.ATV.0000051384.43104.FC","volume":"23","author":"PO Bonetti","year":"2003","unstructured":"Bonetti PO, Lerman LO, Lerman A (2003) Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23(2):168\u2013175","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2297_CR23","first-page":"m627","volume":"368","author":"G Ghirga","year":"2020","unstructured":"Ghirga G (2020) Pre-existing endothelial dysfunction:*m a unifying hypothesis for the burden of severe SARS-CoV-2. BMJ 368:m627","journal-title":"BMJ"},{"key":"2297_CR24","doi-asserted-by":"crossref","first-page":"107246","DOI":"10.1016\/j.carpath.2020.107246","volume":"49","author":"AK Mishra","year":"2020","unstructured":"Mishra AK, Lal A, Sahu KK, Sargent J (2020) Cardiovascular factors predicting poor outcome in COVID\u201419 patients. Cardiovasc Pathol 49:107246","journal-title":"Cardiovasc Pathol"},{"key":"2297_CR25","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1161\/CIRCULATIONAHA.120.047419","volume":"141","author":"CM Campbell","year":"2020","unstructured":"Campbell CM, Kahwash R (2020) Will complement inhibition be the new target in treating COVID-19 related systemic thrombosis. Circulation 141:1739\u20131741","journal-title":"Circulation"},{"issue":"10223","key":"2297_CR26","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet Lond Engl 395(10223):497\u2013506","journal-title":"China Lancet Lond Engl"},{"key":"2297_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25847","author":"AK Mishra","year":"2020","unstructured":"Mishra AK, Sahu KK, Lal A, Sargent J (2020) Patterns of heart Injury in COVID-19 and relation to outcome. J Med Virol. https:\/\/doi.org\/10.1002\/jmv.25847","journal-title":"J Med Virol"},{"key":"2297_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16457","author":"N Epperla","year":"2020","unstructured":"Epperla N, Li A, Logan B, Fretham C, Chhabra S, Aljurf M et al (2020) Incidence, risk factors for and outcomes of transplant-associated thrombotic microangiopathy. Br J Haematol. https:\/\/doi.org\/10.1111\/bjh.16457","journal-title":"Br J Haematol"},{"key":"2297_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00133","author":"CC Dvorak","year":"2019","unstructured":"Dvorak CC, Higham C, Shimano KA (2019) Transplant-associated thrombotic microangiopathy in pediatric hematopoietic cell transplant recipients: a practical approach to diagnosis and management. Front Pediatr. https:\/\/doi.org\/10.3389\/fped.2019.00133","journal-title":"Front Pediatr"},{"key":"2297_CR30","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.bbmt.2011.02.012","volume":"17","author":"HL Haines","year":"2011","unstructured":"Haines HL, Laskin BL, Goebel J, Davies SM, Yin HJ, Lawrence J et al (2011) Blood, and not urine, BK viral load predicts renal outcome in children with hemorrhagic cystitis following hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 17:1512\u20131519","journal-title":"Biol Blood Marrow Transplant"},{"key":"2297_CR31","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.thromres.2020.07.034","volume":"193","author":"N Martinelli","year":"2020","unstructured":"Martinelli N, Montagnana M, Pizzolo F et al (2020) A relative ADAMTS13 deficiency supports the presence of microangiopathy in COVID-19. Thromb Res 193:170\u2013172","journal-title":"Thromb Res"},{"key":"2297_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2020.152001","author":"A Rambaldi","year":"2020","unstructured":"Rambaldi A, Gritti G, Mico MC et al (2020) Endothelial injury and thrombotic microagiopathy in COVID-19: treatment with the lectin-pathway inhibitor narsoplimab. Immunology. https:\/\/doi.org\/10.1016\/j.imbio.2020.152001","journal-title":"Immunology"},{"key":"2297_CR33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13054-020-02897-4","volume":"24","author":"N Rovina","year":"2020","unstructured":"Rovina N, Akinosoglou K, Eugen-Olsen J et al (2020) Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia. Crit Care 24:187","journal-title":"Crit Care"},{"key":"2297_CR34","volume-title":"Molecular biology of the cell","author":"B Alberts","year":"2002","unstructured":"Alberts B, Johnson A, Lewis J et al (2002) Molecular biology of the cell, 4th edn. Garland Science, New York","edition":"4"},{"key":"2297_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2020.05.020","author":"MG Nasab","year":"2020","unstructured":"Nasab MG, Saghazadeh A, Rezaei N (2020) SARS-CoV-2-A tough opponent for the immune system. Arch Med Res. https:\/\/doi.org\/10.1016\/j.arcmed.2020.05.020","journal-title":"Arch Med Res."},{"issue":"7","key":"2297_CR36","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/qjmed\/hcaa117","volume":"113","author":"KK Sahu","year":"2020","unstructured":"Sahu KK, Mishra AK, Lal A (2020) COIVD-19 disease: tackling a pandemic in 21st century. QJM 113(7):519\u2013520","journal-title":"QJM"},{"key":"2297_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.05.013","author":"M Noris","year":"2020","unstructured":"Noris M, Benigni A, Remuzzi G (2020) The case of Complement activation in COVID-19 multiorgan impact. Kidney Int. https:\/\/doi.org\/10.1016\/j.kint.2020.05.013","journal-title":"Kidney Int"},{"issue":"5","key":"2297_CR38","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jfma.2020.03.010","volume":"119","author":"A Lal","year":"2020","unstructured":"Lal A, Mishra AK, Sahu KK (2020) CT chest findings in coronavirus disease-19 (COVID-19). J Formos Med Assoc 119(5):1000\u20131001","journal-title":"J Formos Med Assoc"},{"issue":"1","key":"2297_CR39","first-page":"77","volume":"7","author":"Y Jiang","year":"2018","unstructured":"Jiang Y, Zhao G, Song N, Li P, Chen Y, Guo Y et al (2018) Blockade of the C5a\u2013C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV. Emerg Microbes Infect 7(1):77","journal-title":"Emerg Microbes Infect"},{"issue":"5","key":"2297_CR40","doi-asserted-by":"crossref","first-page":"e01753","DOI":"10.1128\/mBio.01753-18","volume":"9","author":"LE Gralinski","year":"2018","unstructured":"Gralinski LE, Sheahan TP, Morrison TE, Menachery VD, Jensen K, Leist SR et al (2018) Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis. mBio 9(5):e01753","journal-title":"mBio"},{"key":"2297_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","volume":"220","author":"C Magro","year":"2020","unstructured":"Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S, Harp J et al (2020) Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res 220:1\u201313","journal-title":"Transl Res"},{"key":"2297_CR42","doi-asserted-by":"crossref","unstructured":"Lam LM, Murphy SJ, Kuri-Cervantes L, Weisman AR, Ittner CAG, Reilly JP et al (2020) Erythrocytes reveal complement activation in patients with COVID-19. MedRxiv Prepr Serv Health Sci","DOI":"10.1101\/2020.05.20.20104398"},{"key":"2297_CR43","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.29.20041962","author":"T Gao","year":"2020","unstructured":"Gao T, Hu M, Zhang X, Li H, Zhu L, Liu H et al (2020) Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation. Infect Dis. https:\/\/doi.org\/10.1101\/2020.03.29.20041962","journal-title":"Infect Dis"},{"key":"2297_CR44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/bjh.16786","volume":"190","author":"C Lopez","year":"2020","unstructured":"Lopez C, Kim J, Pandey A, Huang T, DeLoughery TG (2020) Simultaneous onset of COVID-19 and autoimmune haemolytic anaemia. Br J Haematol 190:31\u201332","journal-title":"Br J Haematol"},{"key":"2297_CR45","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-019-01249-9","author":"H Hamad","year":"2020","unstructured":"Hamad H, Sahu KK, Dunn S, Milla L, Caffery A, Islam N (2020) Rifampin Induced thrombotic thrombocytopenic purpura. Indian J Hematol Blood Transfus. https:\/\/doi.org\/10.1007\/s12288-019-01249-9","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"4","key":"2297_CR46","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","volume":"124","author":"S Jodele","year":"2014","unstructured":"Jodele S, Davies SM, Lane A, Khoury J, Dandoy C, Goebel J et al (2014) Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults. Blood 124(4):645\u2013653","journal-title":"Blood"},{"issue":"17","key":"2297_CR47","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1056\/NEJMc2007575","volume":"382","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W et al (2020) Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 382(17):e38","journal-title":"N Engl J Med"},{"key":"2297_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1021-2","author":"V Ramlall","year":"2020","unstructured":"Ramlall V, Thangaraj P, Meydan C et al (2020) Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection. Nat Med. https:\/\/doi.org\/10.1038\/s41591-020-1021-2","journal-title":"Nat Med"},{"key":"2297_CR49","doi-asserted-by":"crossref","first-page":"e00638-15","DOI":"10.1128\/mBio.00638-15","volume":"6","author":"AL Totura","year":"2015","unstructured":"Totura AL, Whitmore A, Agnihothram S, Sch\u00e4fer A, Katze MG, Heise MT et al (2015) Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection. mBio 6:e00638-15","journal-title":"mBio"},{"key":"2297_CR50","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa0802437","author":"Z Yang","year":"2008","unstructured":"Yang Z, Stratton C, Francis PJ, Kleinman ME, Tan PL, Gibbs D, Tong Z, Chen H, Constantine R, Yang X, Chen Y (2008) Toll-like receptor 3 and geographic atrophy in age-related macular degeneration. N Engl J Med. https:\/\/doi.org\/10.1056\/nejmoa0802437","journal-title":"N Engl J Med"},{"issue":"1","key":"2297_CR51","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/imr.12467","volume":"274","author":"G Hajishengallis","year":"2016","unstructured":"Hajishengallis G, Lambris JD (2016) More than complementing Tolls: complement-Toll-like receptor synergy and crosstalk in innate immunity and inflammation. Immunol Rev 274(1):233\u2013244","journal-title":"Immunol Rev"},{"key":"2297_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26047","author":"KK Sahu","year":"2020","unstructured":"Sahu KK, Jindal V, Siddiqui AD, Cerny J, Gerber JM (2020) Convalescent plasma therapy: a passive therapy for an aggressive COVID-19. J Med Virol. https:\/\/doi.org\/10.1002\/jmv.26047","journal-title":"J Med Virol"},{"issue":"2","key":"2297_CR53","first-page":"1296","volume":"90","author":"KK Sahu","year":"2020","unstructured":"Sahu KK, Mishra AK, Martin K, Chastain I (2020) COVID-19 and clinical mimics. Correct diagnosis is the key to appropriate therapy. Monaldi Arch Chest Dis Arch Monaldi Mal Torace 90(2):1296","journal-title":"Monaldi Arch Chest Dis Arch Monaldi Mal Torace"},{"issue":"1","key":"2297_CR54","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12967-020-02339-3","volume":"18","author":"B Fu","year":"2020","unstructured":"Fu B, Xu X, Wei H (2020) Why tocilizumab could be an effective treatment for severe COVID-19? J Transl Med 18(1):164","journal-title":"J Transl Med"},{"key":"2297_CR55","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa2007764","volume":"383","author":"JH Beigel","year":"2020","unstructured":"Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC et al (2020) Remdesivir for the treatment of covid-19\u2014preliminary report. N Engl J Med 383:992\u2013994","journal-title":"N Engl J Med"},{"issue":"7","key":"2297_CR56","first-page":"4040","volume":"24","author":"F Diurno","year":"2020","unstructured":"Diurno F, Numis FG, Porta G, Cirillo F, Maddaluno S, Ragozzino A et al (2020) Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience. Eur Rev Med Pharmacol Sci 24(7):4040\u20134047","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"2297_CR57","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41577-020-0320-7","volume":"20","author":"AM Risitano","year":"2020","unstructured":"Risitano AM, Mastellos DC, Huber-Lang M, Yancopoulou D, Garlanda C, Ciceri F et al (2020) Complement as a target in COVID-19? Nat Rev Immunol 20(6):343\u2013344","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"2297_CR58","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41573-019-0031-6","volume":"18","author":"DC Mastellos","year":"2019","unstructured":"Mastellos DC, Ricklin D, Lambris JD (2019) Clinical promise of next-generation complement therapeutics. Nat Rev Drug Discov 18(9):707\u2013729","journal-title":"Nat Rev Drug Discov"},{"key":"2297_CR59","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/s41418-020-0530-3","volume":"27","author":"Y Shi","year":"2020","unstructured":"Shi Y, Wang Y, Shao C, Huang J, Gan J, Huang X et al (2020) COVID-19 infection: the perspectives on immune responses. Cell Death Differ 27:1451\u20131454","journal-title":"Cell Death Differ"},{"key":"2297_CR60","doi-asserted-by":"crossref","first-page":"108450","DOI":"10.1016\/j.clim.2020.108450","volume":"215","author":"S Mastaglio","year":"2020","unstructured":"Mastaglio S, Ruggeri A, Risitano AM, Angelillo P, Yancopoulou D, Mastellos DC et al (2020) The first case of COVID-19 treated with the complement C3 inhibitor AMY-101. Clin Immunol Orlando Fla 215:108450","journal-title":"Clin Immunol Orlando Fla"},{"issue":"1","key":"2297_CR61","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/imr.12467","volume":"271","author":"G Hajishengallis","year":"2016","unstructured":"Hajishengallis G, Lambris JD (2016) More than complementing Tolls: Complement-toll-like receptor synergy and crosstalk in innate immunity and inflammation. Immunol Rev 271(1):233\u2013244","journal-title":"Immunol Rev"},{"key":"2297_CR62","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436","author":"RECOVERY Collaborative Group","year":"2020","unstructured":"RECOVERY Collaborative Group (2020) Dexamethasone in hospitalized patients with Covid-19\u2014preliminary report. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2021436","journal-title":"N Engl J Med"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02297-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-020-02297-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-020-02297-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T13:52:05Z","timestamp":1669211525000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-020-02297-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,15]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["2297"],"URL":"https:\/\/doi.org\/10.1007\/s11239-020-02297-z","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,15]]},"assertion":[{"value":"26 September 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Author has no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The article doesn\u2019t contain the participation of any human being and animal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}